サマリー

抗うつ薬の世界市場 2022-2026 年
Technavioは抗うつ薬市場を監視しており、2022-2026年の間に52億2000万ドルの成長が見込まれ、予測期間中にCAGR5.44%で加速しています。当レポートでは、抗うつ薬市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、うつ病の有病率の上昇、提携・協力関係、うつ病の啓発プログラムによって牽引されています。
抗うつ薬市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの抗うつ薬市場は、以下のようにセグメント化されています。
タイプ別
- 主な強迫性障害
- 強迫性障害
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、新薬の開発・承認が今後数年間の抗うつ薬市場成長を牽引する主要因の1つであると位置付けています。また、ベンダーによる研究開発投資の増加や再生医療の登場は、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。抗うつ薬市場に関する弊社のレポートは、以下の分野を対象としています。
- 抗うつ薬市場のサイジング
- 抗うつ薬市場の予測
- 抗うつ薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Alkermes Public Ltd.、Bausch Health Companies、Co.Ltd.など、いくつかの主要抗うつ剤市場ベンダーについて詳細な分析を提供しています。Ltd.、Bausch Health Companies Inc.、Bristol Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、H Lundbeck AS、Johnson and Johnson、Lupin Ltd. 、Luye Pharma Group Ltd. 、MagVenture AS、Otsuka Holdings Co.大塚製薬株式会社、ファイザー株式会社、SK Biopharmaceuticals Co.大塚ホールディングス株式会社、ファイザー株式会社、SKバイオファーマ株式会社、武田薬品工業株式会社、株式会社エヌ・ティ・ティ・ドコモLtd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.の7社です。また、抗うつ薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/antidepressants-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Major depressive disorder - Market size and forecast 2021-2026
o Exhibit 28: Chart on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Major depressive disorder - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Major depressive disorder - Year-over-year growth 2021-2026 (%)
o 5.4 Obsessive compulsive disorder - Market size and forecast 2021-2026
o Exhibit 32: Chart on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Disease Type
o Exhibit 40: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Greece - Market size and forecast 2021-2026
o Exhibit 66: Chart on Greece - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Greece - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Greece - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Greece - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Alkermes Public Ltd. Co.
o Exhibit 92: Alkermes Public Ltd. Co. - Overview
o Exhibit 93: Alkermes Public Ltd. Co. - Product / Service
o Exhibit 94: Alkermes Public Ltd. Co. - Key news
o Exhibit 95: Alkermes Public Ltd. Co. - Key offerings
o 10.5 Bausch Health Companies Inc.
o Exhibit 96: Bausch Health Companies Inc. - Overview
o Exhibit 97: Bausch Health Companies Inc. - Business segments
o Exhibit 98: Bausch Health Companies Inc. - Key news
o Exhibit 99: Bausch Health Companies Inc. - Key offerings
o Exhibit 100: Bausch Health Companies Inc. - Segment focus
o 10.6 Eli Lilly and Co.
o Exhibit 101: Eli Lilly and Co. - Overview
o Exhibit 102: Eli Lilly and Co. - Product / Service
o Exhibit 103: Eli Lilly and Co. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 H Lundbeck AS
o Exhibit 109: H Lundbeck AS - Overview
o Exhibit 110: H Lundbeck AS - Product / Service
o Exhibit 111: H Lundbeck AS - Key offerings
o 10.9 Johnson and Johnson
o Exhibit 112: Johnson and Johnson - Overview
o Exhibit 113: Johnson and Johnson - Business segments
o Exhibit 114: Johnson and Johnson - Key news
o Exhibit 115: Johnson and Johnson - Key offerings
o Exhibit 116: Johnson and Johnson - Segment focus
o 10.10 Lupin Ltd.
o Exhibit 117: Lupin Ltd. - Overview
o Exhibit 118: Lupin Ltd. - Product / Service
o Exhibit 119: Lupin Ltd. - Key news
o Exhibit 120: Lupin Ltd. - Key offerings
o 10.11 MagVenture AS
o Exhibit 121: MagVenture AS - Overview
o Exhibit 122: MagVenture AS - Product / Service
o Exhibit 123: MagVenture AS - Key offerings
o 10.12 Viatris Inc.
o Exhibit 124: Viatris Inc. - Overview
o Exhibit 125: Viatris Inc. - Business segments
o Exhibit 126: Viatris Inc. - Key offerings
o Exhibit 127: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 11.5 List of abbreviations
o Exhibit 134: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Major depressive disorder - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Major depressive disorder - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Major depressive disorder - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Obsessive compulsive disorder - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Obsessive compulsive disorder - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Disease Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Greece - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Greece - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Greece - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Greece - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Alkermes Public Ltd. Co. - Overview
Exhibits93: Alkermes Public Ltd. Co. - Product / Service
Exhibits94: Alkermes Public Ltd. Co. - Key news
Exhibits95: Alkermes Public Ltd. Co. - Key offerings
Exhibits96: Bausch Health Companies Inc. - Overview
Exhibits97: Bausch Health Companies Inc. - Business segments
Exhibits98: Bausch Health Companies Inc. - Key news
Exhibits99: Bausch Health Companies Inc. - Key offerings
Exhibits100: Bausch Health Companies Inc. - Segment focus
Exhibits101: Eli Lilly and Co. - Overview
Exhibits102: Eli Lilly and Co. - Product / Service
Exhibits103: Eli Lilly and Co. - Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. - Overview
Exhibits105: F. Hoffmann La Roche Ltd. - Business segments
Exhibits106: F. Hoffmann La Roche Ltd. - Key news
Exhibits107: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits108: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits109: H Lundbeck AS - Overview
Exhibits110: H Lundbeck AS - Product / Service
Exhibits111: H Lundbeck AS - Key offerings
Exhibits112: Johnson and Johnson - Overview
Exhibits113: Johnson and Johnson - Business segments
Exhibits114: Johnson and Johnson - Key news
Exhibits115: Johnson and Johnson - Key offerings
Exhibits116: Johnson and Johnson - Segment focus
Exhibits117: Lupin Ltd. - Overview
Exhibits118: Lupin Ltd. - Product / Service
Exhibits119: Lupin Ltd. - Key news
Exhibits120: Lupin Ltd. - Key offerings
Exhibits121: MagVenture AS - Overview
Exhibits122: MagVenture AS - Product / Service
Exhibits123: MagVenture AS - Key offerings
Exhibits124: Viatris Inc. - Overview
Exhibits125: Viatris Inc. - Business segments
Exhibits126: Viatris Inc. - Key offerings
Exhibits127: Viatris Inc. - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations